Acadian Asset Management LLC Gossamer Bio, Inc. Transaction History
Acadian Asset Management LLC
- $57.3 Billion
- Q3 2025
A detailed history of Acadian Asset Management LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 5,012,969 shares of GOSS stock, worth $13.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,012,969
Previous 7,146,022
29.85%
Holding current value
$13.6 Million
Previous $8.79 Million
50.02%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding GOSS
# of Institutions
180Shares Held
163MCall Options Held
8.11MPut Options Held
211K-
Nea Management Company, LLC Timonium, MD18.1MShares$49 Million2.97% of portfolio
-
Octagon Capital Advisors LP New York, NY17.1MShares$46.2 Million14.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$32.5 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$21.8 Million9.24% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.13MShares$16.6 Million6.11% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $255M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...